Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-02-09 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VELAUX (13880), Bouches-du-Rhone
S.E.L.A.R.L PHARMACIE DES OLIVIERS : revenue, balance sheet and financial ratios
S.E.L.A.R.L PHARMACIE DES OLIVIERS is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VELAUX (13880),
this company of category PME
shows in 2020 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - S.E.L.A.R.L PHARMACIE DES OLIVIERS (SIREN 818310682)
Indicator
2024
2022
2021
2020
2019
2017
Revenue
N/C
N/C
N/C
1 958 499 €
1 725 214 €
1 440 963 €
Net income
72 608 €
213 576 €
415 855 €
95 085 €
83 446 €
17 106 €
EBITDA
N/C
N/C
N/C
131 344 €
119 275 €
84 993 €
Net margin
N/C
N/C
N/C
4.9%
4.8%
1.2%
Revenue and income statement
In 2024, S.E.L.A.R.L PHARMACIE DES OLIVIERS generates positive net income of 73 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 17 k€ -> 73 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
72 608 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 60%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
59.556%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.861%
Solvency indicators evolution S.E.L.A.R.L PHARMACIE DES OLIVIERS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2024
Debt ratio
1390.048
537.27
371.895
140.535
96.862
59.556
Financial autonomy
4.864
13.422
17.926
34.673
43.76
51.861
Repayment capacity
17.017
14.743
13.09
None
None
None
Cash flow / Revenue
4.563%
4.59%
4.524%
None%
None%
None%
Sector positioning
Debt ratio
59.562024
2021
2022
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-11 pts over 3 years
In 2024, the debt ratio of S.E.L.A.R.L PHARMACIE DES... (59.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
51.86%2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+16 pts over 3 years
In 2024, the financial autonomy of S.E.L.A.R.L PHARMACIE DES... (51.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution S.E.L.A.R.L PHARMACIE DES OLIVIERS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2024
Operating WCR
-87 481 €
-66 317 €
-70 173 €
0 €
0 €
0 €
Inventory turnover (days)
57
0
0
0
0
0
Customer payment term (days)
1
0
0
0
0
0
Supplier payment term (days)
41
44
47
0
0
0
Positioning of S.E.L.A.R.L PHARMACIE DES OLIVIERS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of S.E.L.A.R.L PHARMACIE DES OLIVIERS is estimated at
1 013 661 €
(range 705 897€ - 1 516 495€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
705k€1013k€1516k€
1 013 661 €Range: 705 897€ - 1 516 495€
NAF 5 année 2024
Valuation method used
Net Income Multiple
72 608 €
×
14.0x
=1 013 661 €
Range: 705 898€ - 1 516 495€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare S.E.L.A.R.L PHARMACIE DES OLIVIERS with other companies in the same sector:
Frequently asked questions about S.E.L.A.R.L PHARMACIE DES OLIVIERS
What is the revenue of S.E.L.A.R.L PHARMACIE DES OLIVIERS ?
The revenue of S.E.L.A.R.L PHARMACIE DES OLIVIERS in 2020 is 2.0 M€.
Is S.E.L.A.R.L PHARMACIE DES OLIVIERS profitable?
Yes, S.E.L.A.R.L PHARMACIE DES OLIVIERS generated a net profit of 73 k€ in 2024.
Where is the headquarters of S.E.L.A.R.L PHARMACIE DES OLIVIERS ?
The headquarters of S.E.L.A.R.L PHARMACIE DES OLIVIERS is located in VELAUX (13880), in the department Bouches-du-Rhone.
Where to find the tax return of S.E.L.A.R.L PHARMACIE DES OLIVIERS ?
The tax return of S.E.L.A.R.L PHARMACIE DES OLIVIERS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does S.E.L.A.R.L PHARMACIE DES OLIVIERS operate?
S.E.L.A.R.L PHARMACIE DES OLIVIERS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart